查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1841943

美國人工角膜植入市場：市場規模、佔有率、趨勢分析（按移植類型、適應症、植入類型、最終用途）、細分市場預測（2025-2033）

U.S. Artificial Corneal Implants Market Size, Share & Trends Analysis Report By Transplant Type, By Indication, By Implant Type, By End-use, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10個工作天內

價格

美國人工角膜植入市場摘要

預計 2024 年美國人工角膜植入市場價值為 3,910 萬美元，到 2033 年將達到 6,980 萬美元，2025 年至 2033 年的複合年成長率為 6.7%。

市場的發展受到角膜疾病（如角膜失明）盛行率的不斷上升以及角膜捐贈者的短缺的推動，導致患者和外科醫生尋求人工替代方案。

圓錐角膜、史蒂文斯-約翰遜症候群和角膜瘢痕等視力障礙主要病因的增多，推動了市場的發展。隨著美國人口老化，這些疾病的發生率不斷上升，進一步推動了對有效治療方法的需求。根據美國國家老齡委員會的數據，到2022年，美國65歲及以上成年人口將達到5,780萬，其中包括3,190萬名女性和2,590萬男性。

為了滿足這項需求，主要市場參與企業正在大力投資研發、獲得監管部門的核准，並與臨床和學術機構合作推出創新的植入解決方案。夥伴關係、地理擴張和先進生醫材料的整合等策略性舉措將加強競爭地位並擴大市場範圍。 2025 年 1 月，Pantheon Vision 與 Ideal Medical 合作，推進生物工程植入的生產和商業化。 Pantheon 已完成三次 FDA 上市前核准(PMA) 指南審查會議。此次合作旨在透過提供生物工程角膜植入來解決捐贈角膜的局限性，從而為角膜失明患者恢復視力。

目錄

第1章 分析方法與範圍

第2章執行摘要

第3章人工角膜植入市場：因素、趨勢與範圍

  • 市場概況/相關展望
  • 市場規模和成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 美國人工角膜植入市場：分析工具
    • 波特五力分析
    • PESTEL分析

第4章美國人工角膜植入市場：按植入物類型進行的估計和趨勢分析

  • 細分儀表板
  • 美國人工角膜植入市場分析（按植入物類型）（2024 年和 2033 年）
  • 硬性人工替代物
    • 硬性人工替代物：收益估計值與預測（2021-2033）
    • 波士頓 K 職業隊
    • 根角人工替代物
  • 軟性人工替代物
    • 軟性人工替代物：收益估計值與預測（2021-2033）

第5章美國人工角膜植入市場：依適應症的估計與趨勢分析

  • 細分儀表板
  • 美國人工角膜植入市場分析（依適應症分類）（2024 年和 2033 年）
  • 史蒂文斯-約翰遜症候群（SJS）
    • 史蒂文斯-約翰遜症候群 (SJS)：收益估計值和預測（2021-2033）
  • 眼部瘢痕性類天皰瘡（OCP）
    • 眼部瘢痕性類天皰瘡 (OCP)：收益估計值與預測（2021-2033）
  • 眼部燒燙傷
    • 眼燒傷：收益估計值與預測（2021-2033）
  • 圓錐角膜
    • 圓錐角膜：收益估計值與預測（2021-2033）
  • 角膜基質營養不良
    • 角膜基質營養不良：收益估計值和預測（2021-2033）
  • 其他
    • 2021-2033年其他收益估算與預測

第6章美國人工角膜植入市場：按植入類型進行的估計和趨勢分析

  • 細分儀表板
  • 美國人工角膜植入市場分析（按植入類型）（2024 年和 2033 年）
  • 合成
    • 綜合：收益估計值與預測（2021-2033）
  • 生物合成
    • 生物合成：收益估計值與預測（2021-2033）

第7章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
  • 公司熱圖分析
  • 公司簡介
    • CorneaGen
    • AJL Ophthalmic SA
    • Alcon inc.
    • KeraMed, Inc.
    • FCI
Product Code: GVR-4-68040-757-7

U.S. Artificial Corneal Implants Market Summary

The U.S. artificial corneal implants market size was estimated at USD 39.1 million in 2024 and is projected to reach USD 69.8 million by 2033, growing at a CAGR of 6.7% from 2025 to 2033. The market is driven by an increasing prevalence of corneal disorders such as corneal blindness and a shortage of cornea donors, which is leading patients and surgeons to seek synthetic alternatives.

The market is driven by increasing incidences of Keratoconus, Stevens-Johnson syndrome, and corneal scarring, which remain leading causes of vision impairment. The increasing prevalence of these disorders among the aging U.S. population has further increased the need for effective treatment solutions. According to the National Council on Aging, in 2022, the U.S. had 57.8 million adults aged 65 and older, comprising 31.9 million women and 25.9 million men.

To address this demand, key market participants invest heavily in R&D, securing regulatory approvals, and collaborating with clinical and academic institutions to introduce innovative implant solutions. Strategic initiatives, including partnerships, geographic expansion, and integration of advanced biomaterials, enhance their competitive positioning and expand market reach. In January 2025, Pantheon Vision collaborated with Eyedeal Medical to advance production and commercialization of its bioengineered corneal implant. Pantheon completed three FDA review meetings for Premarket approval (PMA) guidance. The partnership aimed to address limitations of donor corneas by offering bioengineered corneal implants and restoring vision in patients with corneal blindness.

U.S. Artificial Corneal Implants Market Report Segmentation

This report forecasts revenue growth at country level as well as provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. artificial corneal implants market report on the basis of transplant type, indication, implant type, and end-use:

  • Transplant Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Hard Keratprosthesis
    • Boston Kpro
    • Osteo-Odonto-Keratoprosthesis
  • Soft Keratoprosthesis
  • Indication Outlook (Revenue, USD Million, 2021 - 2033)
  • Stevens-Johnson Syndrome (SJS)
  • Ocular Cicatricial Pemphigoid (OCP)
  • Ocular burns
  • Keratoconus
  • Corneal Stromal Dystrophies
  • Others
  • Implant Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Synthetic
  • Biosynthetic
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Ophthalmic Centers
  • Ambulatory Surgical Centers

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
  • 1.4. Information Procurement
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Artificial Corneal Implants Market Variables, Trends & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. U.S. Artificial Corneal Implants Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Political landscape
      • 3.4.1.2. Economic and Social landscape
      • 3.4.1.3. Technological landscape
      • 3.4.1.4. Environmental landscape
      • 3.4.1.5. Legal landscape
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Bargaining power of the suppliers
      • 3.4.2.2. Bargaining power of the buyers
      • 3.4.2.3. Threats of substitution
      • 3.4.2.4. Threats from new entrants
      • 3.4.2.5. Competitive rivalry

Chapter 4. U.S. Artificial Corneal Implants Market: Transplant Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Artificial Corneal Implants Market: Transplant Type Analysis, 2024 & 2033 (USD Million)
  • 4.3. Hard Keratoprosthesis
    • 4.3.1. Hard Keratoprosthesis Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.2. Boston Kpro
      • 4.3.2.1. Boston Kpro Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.3. Osteo-Odonto-Keratoprosthesis
      • 4.3.3.1. Osteo-Odonto-Keratoprosthesis Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Soft Keratoprosthesis
    • 4.4.1. Soft Keratoprosthesis Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Artificial Corneal Implants Market: Indication Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Artificial Corneal Implants Market: Indication Analysis, 2024 & 2033 (USD Million)
  • 5.3. Stevens-Johnson syndrome (SJS)
    • 5.3.1. Stevens-Johnson syndrome (SJS) Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Ocular Cicatricial Pemphigoid (OCP)
    • 5.4.1. Ocular Cicatricial Pemphigoid (OCP) Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Ocular Burns
    • 5.5.1. Ocular Burns Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Keratoconus
    • 5.6.1. Keratoconus Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Corneal Stromal Dystrophies
    • 5.7.1. Corneal Stromal Dystrophies Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Others
    • 5.8.1. Others Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Artificial Corneal Implants Market: Implant Type Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Artificial Corneal Implants Market: Implant Type Analysis, 2024 & 2033 (USD Million)
  • 6.3. Synthetic
    • 6.3.1. Synthetic Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Biosynthetic
    • 6.4.1. Biosynthetic Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. CorneaGen
      • 7.4.1.1. Company Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. AJL Ophthalmic S.A.
      • 7.4.2.1. Company Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. Alcon inc.
      • 7.4.3.1. Company Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. KeraMed, Inc.
      • 7.4.4.1. Company Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. FCI
      • 7.4.5.1. Company Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. artificial corneal implants market 2021 - 2033 (USD Million)
  • Table 3 U.S. artificial corneal implants market: key market driver analysis
  • Table 4 U.S. artificial corneal implants market: key market restraint analysis
  • Table 5 U.S. artificial corneal implants market estimates and forecast, by transplant type (USD Million)
  • Table 6 U.S. artificial corneal implants market estimates and forecast, by indication (USD Million)
  • Table 7 U.S artificial corneal implants market estimates and forecast, by implant type (USD Million)
  • Table 8 U.S artificial corneal implants market estimates and forecast, by end use (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 U.S. artificial corneal implants: market outlook
  • Fig. 10 U.S. artificial corneal implants competitive insights
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Industry value chain analysis
  • Fig. 15 U.S. artificial corneal implants driver impact
  • Fig. 16 U.S. artificial corneal implants restraint impact
  • Fig. 17 U.S. artificial corneal implants strategic initiatives analysis
  • Fig. 18 U.S. artificial corneal implants: Transplant type movement analysis
  • Fig. 19 U.S. artificial corneal implants: Transplant type outlook and key takeaways
  • Fig. 20 Hard keratoprosthesis estimates and forecast, 2021 - 2033
  • Fig. 21 Boston Kpro estimates and forecast, 2021 - 2033
  • Fig. 22 Osteo-odonto-keratoprosthesis estimates and forecast, 2021 - 2033
  • Fig. 23 Soft keratoprosthesis estimates and forecast, 2021 - 2033
  • Fig. 24 U.S. artificial corneal implants: Indication movement analysis
  • Fig. 25 U.S. artificial corneal implants: Indication outlook and key takeaways
  • Fig. 26 Stevens-Johnson syndrome (SJS) estimates and forecasts, 2021 - 2033
  • Fig. 27 Ocular cicatricial pemphigoid (OCP) estimates and forecasts, 2021 - 2033
  • Fig. 28 Ocular burn estimates and forecasts, 2021 - 2033
  • Fig. 29 Keratoconus estimates and forecasts, 2021 - 2033
  • Fig. 30 Corneal stromal dystrophies estimate and forecasts, 2021 - 2033
  • Fig. 31 OtherOthers estimates and forecasts, 2021 - 2033
  • Fig. 32 U.S. artificial corneal implants: Implant type movement analysis
  • Fig. 33 U.S. artificial corneal implants: Implant type outlook and key takeaways
  • Fig. 34 Synthetic estimates and forecasts, 2021 - 2033
  • Fig. 35 Biosynthetic estimates and forecasts, 2021 - 2033
  • Fig. 36 U.S. artificial corneal implants: End use movement analysis
  • Fig. 37 U.S. artificial corneal implants: End use outlook and key takeaways
  • Fig. 38 Hospitals estimates and forecasts, 2021 - 2033
  • Fig. 39 Ophthalmic center estimates and forecasts, 2021 - 2033
  • Fig. 40 Ambulatory surgical center estimates and forecasts, 2021 - 2033